Journal rankings · indicator year 2019
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2019
Cancer Research journal rankings 2019
27 ranked journals · Subfield in Biochemistry, Genetics and Molecular Biology
Cancer Research has 27 ranked journals in 2019. The median journal has an OJR of 0.82, below the world average of 1.00, up 0.01 on 2018; Q1 starts at OJR 1.17. The top three are Biomarker Insights, Cancer & Metabolism, and Journal of Molecular Diagnostics.
Ranks and citation indicators: 2019. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2016–2018, the window the 2019 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Biochemistry, Genetics and Molecular Biology (14)
27 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2018. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2016–2018, the window the 2019 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2016–2018 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2010 to 2019. | Compare |
|---|---|---|---|---|---|---|---|
1Biomarker InsightsOASAGE Publishing · United Kingdom | 2.07Q1 | 5.34 2.34 up from 2018 | 61 | 100% | $2,650 | ||
2Cancer & MetabolismOABioMed Central · United Kingdom | 1.90Q1 | 6.27 1.13 down from 2018 | 52 | 100% | $3,190 | ||
3Journal of Molecular DiagnosticsElsevier BV · United States | 1.80Q1 | 4.48 0.75 down from 2018 | 297 | 100% | $3,000 | ||
4Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 1.75Q1 | 5.68 0.61 down from 2018 | 127 | 35% | $4,160 | ||
5BiomedicineOAEDP Sciences · Netherlands | 1.41Q1 | 4.06 1.70 down from 2018 | 77 | 100% | — | ||
6Non-coding RNA ResearchOAElsevier BV · China | 1.29Q1 | 5.23 2.01 up from 2018 | 55 | 100% | $1,100 | ||
7Breast Cancer Research and TreatmentSpringer Science+Business Media · Netherlands | 1.17Q1 | 3.99 0.22 up from 2018 | 1,337 | 46% | $4,190 | ||
8Non-Coding RNAOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.15Q2 | 5.22 2.32 up from 2018 | 82 | 100% | $2,172 | ||
9Breast Cancer Basic and Clinical ResearchOASAGE Publishing · United States | 1.06Q2 | 3.15 0.03 down from 2018 | 59 | 100% | $2,650 | ||
10The BreastOAElsevier BV · United Kingdom | 1.04Q2 | 3.47 0.15 down from 2018 | 581 | 12% | $3,200 | ||
11MutagenesisOxford University Press · United Kingdom | 0.95Q2 | 2.80 0.36 down from 2018 | 153 | 43% | $4,170 | ||
12Environmental and Molecular MutagenesisWiley · United States | 0.91Q2 | 3.32 0.62 up from 2018 | 231 | 42% | $3,750 | ||
13Genes and EnvironmentOABioMed Central · Japan | 0.85Q2 | 1.95 1.19 down from 2018 | 86 | 100% | $2,590 | ||
14Journal of Breast CancerOASouth Korea | 0.82Q2 | 2.57 0.42 down from 2018 | 177 | 100% | $500 | ||
15Breast CancerSpringer Science+Business Media · Japan | 0.80Q3 | 2.65 0.23 up from 2018 | 278 | 28% | $3,890 | ||
16Clinical Breast CancerElsevier BV · United States | 0.77Q3 | 2.72 0.32 up from 2018 | 477 | 23% | $3,470 | ||
17Mutation Research/Genetic Toxicology and Environmental MutagenesisElsevier BV · Netherlands | 0.76Q3 | 2.38 0.22 up from 2018 | 351 | 35% | $3,350 | ||
18Pathology - Research and PracticeElsevier BV · Germany | 0.72Q3 | 2.36 0.59 up from 2018 | 794 | 12% | $2,780 | ||
19Critical Reviews in Eukaryotic Gene ExpressionBegell House · United States | 0.72Q3 | 2.39 0.87 up from 2018 | 97 | 2% | — | ||
20MicroRNABentham Science Publishers · Netherlands | 0.65Q3 | 2.76 1.45 up from 2018 | 96 | 66% | — | ||
21British Journal of Biomedical ScienceOATaylor & Francis · United Kingdom | 0.54Q3 | 2.38 0.51 up from 2018 | 126 | 5% | $2,506 | ||
22The Breast JournalOAWiley · United Kingdom | 0.52Q4 | 1.43 0.11 down from 2018 | 470 | 77% | $2,350 | ||
23Breast DiseaseIOS Press · Netherlands | 0.30Q4 | 1.03 0.14 down from 2018 | 63 | 2% | — | ||
24Breast Diseases A Year Book QuarterlyElsevier BV · Netherlands | 0.16Q4 | —no 2018 value | 151 | — | — | ||
25Non-coding RNA InvestigationOAAME Publishing Company · Hong Kong SAR China | 0.15Q4 | 0.54 0.27 down from 2018 | 63 | 100% | — | ||
26Journal of Biomaterials and Tissue EngineeringAmerican Scientific Publishers · United States | 0.13Q4 | 0.31 0.12 down from 2018 | 525 | 0% | — | ||
27International Journal of Human GeneticsOAKamla Raj Enterprises · India | 0.09Q4 | 0.15 0.08 down from 2018 | 108 | 100% | — |
Subfields of Biochemistry, Genetics and Molecular Biology, with Cancer Research highlighted.
- Molecular Biology1,157
- Genetics127
- Cell Biology28
- Cancer Research27
- Molecular Medicine11
- Biophysics7
- Clinical Biochemistry5
- Structural Biology3
- Biochemistry2
- Developmental Biology1
- Physiology1
- Aging0
- Biotechnology0
- Endocrinology0
Journals
Citations made in 2019. Corpus-wide, 83.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
18 additional Cancer Research journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2016–2018, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2019. Publication window: 2016–2018. How these summaries are calculated
- Ranked journals
- 27
- Window papers (baseline)
- 54,530 +9.0% from indicator year 2016
- Median OJR
- 0.82 +2.7% from indicator year 2016
- Rising journals (2025)
- 2
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2016–2018 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 12 | 14 | 15 | 16 | 16 | 19 | 20 | 21 | 21 | 22 | 21 | 20 | 21 | 24 | 23 | 25 | 26 | 27 | 28 | 27 | 29 | 27 | 27 | 26 | 27 | 29 | |
| Window papers (baseline) | 14,247 | 15,312 | 16,615 | 17,745 | 18,774 | 20,529 | 22,718 | 25,259 | 27,535 | 30,135 | 32,914 | 35,940 | 38,839 | 41,424 | 44,722 | 47,640 | 50,019 | 51,182 | 52,328 | 54,530 | 57,576 | 61,698 | 64,508 | 64,646 | 60,806 | 56,699 | |
| Median OJR | 0.49 | 0.50 | 0.46 | 0.60 | 0.71 | 0.58 | 0.67 | 0.680 | 0.768 | 0.8139 | 0.72 | 0.798 | 0.93 | 0.92 | 0.88 | 0.84 | 0.7969 | 0.8143 | 0.804 | 0.82 | 0.76 | 0.679 | 0.70 | 0.79 | 0.770 | 0.7966 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.